Exhaled nitric oxide is reduced in infants with cystic fibrosis

Thorax

Volumn 56, Issue 2, 2001, Pages 151-152

  Elphick, H E ^a   Demoncheaux, E A G ^b   Ritson, S ^a   Higenbottam, T W ^b   Everard, M L ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Nitric oxide; Paediatrics

Indexed keywords

NITRIC OXIDE;

ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; INFANT; INFANT DISEASE; INFLAMMATORY DISEASE; NEWBORN; PRIORITY JOURNAL;

BREATH TESTS; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; CYSTIC FIBROSIS; HUMANS; INFANT; INFANT, NEWBORN; NITRIC OXIDE; STATISTICS, NONPARAMETRIC;

EID: 0035130495     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.2.151     Document Type: Article

References (5)

1. Early pulmonary inflammation in infants with cystic fibrosis
2. Exhaled nitric oxide in paediatric asthma and cystic fibrosis
3. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide
4. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression
5. Inhaled nitric oxide reduces the sequestration of activated polymorphonuclear leukocytes in the lung